Introduction
============

Endemic regions of Crimean Congo Hemorrhagic Fever (CCHF) have been reported in Africa, the Middle East, Eastern Europe and Western Asia ([@B14]). In the past 10 years, Turkey, Bosnia, and Iran have been reported the most frequent outbreaks of CCHF worldwide ([@B23]).

The virus is transmitted to humans through the bite of infected Ixodid ticks (mostly of the *Hyalomma* genus) ([@B22], [@B5]), or direct contact with infected blood, by meat from infected animals or by nosocomial transmission ([@B9]).

CCHFV is a single stranded RNA virus with segmented negative sense genome consisting of a small (S), a medium (M) and a large (L) segment. The S RNA segment encodes the nucleocapsid (N) protein, and the M RNA segment encodes the glycoprotein precursor, resulting in the two envelope glycoproteins Gn and Gc, while the L segment encodes the putative RNA-dependent "RNA" polymerase ([@B27]). It has been proved that segmented RNA viruses have the potential of segment reassortment and form new distinct genomic variants if the host cells are subject to dual infection by more than one genetically distinct virus ([@B18], [@B20]).

CCHFVs are relatively divergent in their genome sequence and grouped geographically into seven distinct clades based on the S-segment sequence analysis ([@B16]). West-Africa in clade I, Central Africa in clade II, South-Africa and West-Africa in clade III, Middle-East and Asia in clade IV, Europe in clade V and Greece in clade VI ([@B12], [@B17]). The clade IV may be devided into two distinct clades, Asia-1 and Asia-2 ([@B17]).

Beside the genome analysis on S segment, CCHFVs are divided into six clades based on M-RNA sequences; clade IV (Asia or Middle East) comprising strains in China, Pakistan, Oman, and South Africa, clade III (S Africa or W Africa 2) comprising those in Uzbekistan, Tajikistan, China, Pakistan, Iran, Iraq, South Africa and Nigeria, clade I (W Africa1) comprising those in Congo, Senegal, China, clade V (Europe) comprising those in Russia, Kosovo and Turkey, clade VI (Greece) including isolated strain from Greece, and clade VII (Mauritania) including isolated strain from Mauritania ([@B26], [@B25], [@B24]).

In Iran, the first phylogenetic study on S-segment of CCHFV in 2004 showed that the CCHFV strains were clustered within clade Asia 1 with the highest similarity to Matin strain from Pakistan ([@B11]), previously a pioneering genetic characterization study had showed that the Iranian strain (ArTeh 193-3) obtained from ticks in the North-Eastern region of Khorasan Province in 1978 clustered within clade Africa I and had similarity with CCHFV strains from West Africa, mainly from Senegal and Mauritania ([@B31]).

In 2008, further phylogenetic analysis in tick populations in Isfahan province in Central Iran, demonstrated that a variant strain clustered within clade IV (Asia 1) with the highest similarity to an Iraqi strain ([@B8]).

Genetic analyses in 2012 of one strain from Northern Iran illustrated that the Russian CCHFV genome is circulating in this area, and accordingly the existence of European clade V in Iran was confirmed ([@B7]).

According to the previous phylogenetic studies, there are seven clades of CCHFV and Iranian strains of CCHFV distributed within three clade I (Africa I), clade IV (Asia 1) and clade V (Europe) ([@B7]).

The main objective of this study was to obtain new insights into the molecular epidemiology of CCHFV in Iran by analyzing the partial and complete nucleotide sequences of the S and M segments of CCHFV genome obtained from Iranian patients and several sequences available from GenBank.

Materials and Methods
=====================

Investigation areas and sampling
--------------------------------

According to the distribution of CCHFV in Iran, CCHFV have been reported from 27 of 31 provinces until now. Nineteen provinces encompassed all geographical areas and were randomly selected and investigated in a span of 11 years between 2002 and 2013. A total of 50 human sera samples were selected among previously RT-PCR positive samples which were stored in the Arboviruses and Viral Hemorrhagic Fevers Laboratory (National Ref. Lab) sample bank; Pasteur Institute of Iran and also transferred samples to the this laboratory during the study. Geographical distribution and the year of sampling related to each strain are shown in [Table 1](#T1){ref-type="table"}.

###### 

Details of the Iranian CCHFV strains isolated from human serum used in this study. The sequences used for analysis of partial S, complete S and partial M segments are indicated in table

  **Strain**                      **Location**   **Date**   **Partial S**   **Complete S**   **Partial M**
  ------------------------------- -------------- ---------- --------------- ---------------- ---------------
  **Iran-KhRazavi/1**             Northeast      2013       \*                               
  **Iran-KhRazavi/2**             Northeast      2012       \*                               
  **Iran-KhRazavi/3**             Northeast      2012       \*                               
  **Iran-KhRazavi/4**             Northeast      2012       \*                               
  **Iran-KhRazavi/5**             Northeast      2012       \*                               
  **Iran-KhRazavi/16**            Northeast      2012       \*                               
  **Iran-KhRazavi/17**            Northeast      2012       \*                               
  **Iran-KhRazavi/80**            Northeast      2012       \*                               
  **Iran-KhRazavi/72**            Northeast      2012       \*              \*               \*
  **Iran-Kerman/22**              Southeast      2012       \*              \*               \*
  **Iran-Kerman/27**              Southeast      2012       \*                               
  **Iran-Kerman/24**              Southeast      2006       \*                               
  **Iran-Zahedan/25**             Southeast      2012       \*                               
  **Iran-Zahedan29**              Southeast      2012       \*                               
  **Iran-Kerman/43**              Southeast      2013       \*              \*               \*
  **Iran-Zahedan/74**             Southeast      2012       \*                               
  **Iran-Kerman/77**              Southeast      2013       \*                               
  **Iran-SistanBalochestan/85**   Southeast      2011       \*                               
  **Iran-Zahedan/19**             Southeast      2012       \*              \*               
  **Iran-Zahedan/20**             Southeast      2012       \*                               
  **Iran-Shiraz/39**              South          2012       \*                               
  **Iran-Minab/49**               South          2007       \*                               
  **Iran-BandarAbas/50**          South          2011       \*                               
  **Iran-Hormozgan/84**           South          2011       \*                               
  **Iran-Booshehr/52**            South          2010       \*                               
  **Iran-Hormozgan/87**           South          2011       \*                               
  **Iran-Fars/89**                South          2011       \*                               
  **Iran-Booshehr/97**            South          2002       \*                               
  **Iran-KhJonobi/73**            East           2012       \*                               
  **Iran-Zanjan/23**              West           2012       \*                               
  **Iran-Zanjan/41**              West           2006       \*                               
  **Iran-Kermanshah/55**          West           2008       \*                               
  **Iran-KhorramAbad/56**         West           2010       \*                               
  **Iran-Ahvaz/54**               Southwest      2010       \*                               
  **Iran-Yazd/57**                Central        2009       \*                               
  **Iran-Qom/58**                 Central        2011       \*                               
  **Iran-Tehran/65**              Central        2011       \*              \*               \*
  **Iran-Isfahan/78**             Central        2013       \*              \*               \*
  **Iran-Isfahan/81**             Central        2011       \*                               
  **Iran-Kashan/15**              Central        2005       \*                               
  **Iran-Qom/71**                 Central        2008       \*                               
  **Iran-Yazd/86**                Central        2010       \*                               
  **Iran-Tehran/90**              Central        2012       \*                               
  **Iran-Tehran/91**              Central        2010       \*                               
  **Iran-Tabriz/99**              Northwest      2003       \*                               
  **Iran-Oroomieh/100**           Northwest      2003       \*                               
  **Iran-Tabriz/102**             Northwest      2004       \*                               
  **Iran-Babol/14**               North          2012       \*                               
  **Iran-Amlash/21**              North          2012       \*                               
  **Iran-Gilan/69**               North          2012       \*              \*               \*

Serological and molecular identification
----------------------------------------

To investigate each human serum sample for the presence of CCHFV-specific antibodies, an ELISA was initially used to detect IgM ([@B15]). Molecular analysis was subsequently applied. For this purpose, viral RNA was extracted from 140 μl of serum using a QIAamp RNA Mini kit, according to of the manufacturer's instructions (QI Agen GmbH, Hilden, Germany) ([@B34]). Specific primers for amplification of partial S, whole S and M segments were designed by CLC main workbench software version 5.0, based on available CCHFV sequences in GenBank.

To amplify the partial of the S-segment, a primer pair (PSF5′-GAATGTGCATGGGTT AGCTC-3′) and (PSR 5′-GACATCACAA TTTCACCAGG-3′) was designed and used to amplify a 536 bp section. For reverse transcription, 50 °C (30 min) used. An initial enzyme activation step at 95 °C for 5 min was succeeded by 40 reaction cycles carried out with 30 sec at 94 °C, 30 sec at 50 °C, and 45 sec at 72 °C followed by a final incubation at 72 °C for 10 min.

For amplification of the full-length of the S-segment, a touch down RT-PCR used with the following primers: WSF: 5′-TCTCAAAGAAACACGTGCCGC-3′ and WSR: 5′-TCTCAAAGATATCGTTGCCGC-3′ to amplify a 1680 bp section of the S-segment. Thermal cycle condition designed as 45 °C (30 min) for reverse transcription and 95 °C (15 min) as an initial enzyme activation, and then followed by 40 reaction cycles at 94 °C (10 sec), 66-52 °C (30 sec), 68 °C (100 sec), eventually, 68 °C (10 min) as final extension.

For amplification of the partial of the M-segment, the primers of PMF 5′-TGCAC TTGAGCATCTGCAA-3′ and PMR 5′-AG CTGATTCCTGTCCTTTC-3′ was designed and used to amplify a 557 bp section of the M-segment. For reverse transcription, 50 °C (30 min) used An initial enzyme activation step at 95 °C for 15 min was succeeded by 40 reaction cycles carried out with 30 sec at 94 °C, 30 sec at 45 °C, and 1 min at 72 °C followed by a final incubation at 72 °C for 10 min ([@B28]). PCR products were amplified using one-step RT-PCR, according to Rodriguez et al. The amplified products were visualized by ethidium bromide agarose gel staining ([@B33]).

Sequencing
----------

The PCR products were then sequenced using Big Dye Terminator V3.1 Cycle sequencing Kit with Modified Sanger Sequencing Method by ABI Genetic Analyzer 3130. For full-length S-segment sequencing, internal primers were designed as follow: Forward: 3′AATGCAAACACGGCAGCTTT5′ and Reverse: 3′GGAACTGTGAGACAG TCGGG5′. The obtained sequences were optimized (gaps and noises were deleted) ([@B10]).

Nucleotide sequence accession numbers
-------------------------------------

Whole S segment isolates Iran-Gilan 69, Iran-Isfahan 78, Iran-Kerman 43, Iran-Kh Razavi 72, Iran-Tehran 65 and Iran-Zahedan 19 submitted to GenBank and assigned accession No. KJ027521, KJ027522, KJ196326, KJ485700, KJ566219 and KJ676542 respectively.

Sequence alignments and phylogeny analysis
------------------------------------------

In addition to the 50 CCHFV sequences obtained, several sequences available from GenBank at [www.ncbi.nih.gov](www.ncbi.nih.gov) were incorporated into the alignments for phylogenetic analyses ([Table 2](#T2){ref-type="table"}).

###### 

Details of CCHF virus strains originated from Iran and other countries retrieved from GenBank and used for sequence analysis

  **Virus strains**        **Location**   **Date**   **Clade/Name (S segment)**   **GenBank accession no S segment**   **Clade/Name (M segment)**   **GenBank accession no M segment**
  ------------------------ -------------- ---------- ---------------------------- ------------------------------------ ---------------------------- ------------------------------------
  **NIV 112143**           India          2011       IV/ASI-1                     JN572089                             \-                           \-
  **SCT ex Afghanistan**   Afghanistan    2012       IV/ASI-1                     JX908640                             \-                           \-
  **Afg09-2990**           Afghanistan    2009       IV/ASI-1                     HM452305                             \-                           \-
  **ArTec193-3**           Iran           1978       I/WAFR-1                     U15022                               \-                           \-
  **766/02**               Iran           2004       IV/ASI-1                     AY366373                             \-                           \-
  **787/02**               Iran           2004       IV/ASI-1                     AY366379                             \-                           \-
  **Iran 52**              Iran           2002       \-                           \-                                   III/S AFR,WAFR-2             DQ446215
  **Iran53**               Iran           2002       \-                           \-                                   III/S AFR,WAFR-2             DQ446216
  **Baghadad12**           Iraq           1979       IV/ASI-1                     AJ538196                             III/S AFR,WAFR-2             AJ538197
  **China79121**           China          1979       IV/ASI-2                     AF358784                             I/W AFR-1                    AB069673
  **ChinaC68031**          China          1968       \-                           \-                                   IV/ASI                       DQ211629
  **Kosovo 1917**          Kosovo         2009       V/EUR                        JN173797                             \-                           \-
  **Kososvo9553**          Kosovo         2001       \-                           \-                                   V/EUR                        AY675511
  **KosovoHoti**           Kosovo         2001       \-                           \-                                   V/EUR                        EU037902
  **ArMg951**              Madagaskar     1994       IV/ASI-1                     U15024                               \-                           \-
  **IbAr10200**            Nigeria        1966       III/S AFR,W AFR-2            U88410                               III/S AFR,W AFR-2            AF467768
  **Matin**                Pakistan       1976       IV/ASI-1                     AF527810                             4/ASI                        AF467769
  **PakistanSR3**          Pakistan       2000       IV/ASI-1                     AJ538198                             III/S AFR,W AFR-2            AJ538199
  **Drosdov**              Russia         1967       V/EUR                        DQ211643                             V/EUR                        DQ211630
  **Kashmanov**            Russia         1967       V/EUR                        DQ211644                             V/EUR                        DQ211631
  **SPU 128817**           South Africa   1981       III/S AFR,W AFR-2            DQ076415                             III/S AFR,W AFR-2            DQ157174
  **SPU9785**              South Africa   1985       III/S AFR,W AFR-2            DQ211646                             IV/ASI                       DQ211633
  **ArD39554**             Mauritania     1984       III/S AFR,W AFR-2            DQ211641                             VII/MAURITANIA               DQ211628
  **AB1-2009**             Sudan          2009       \-                           \-                                   III/S AFR,W AFR-2            HQ378187
  **ArD8194**              Senegal        1969       I/W AFR-1                    DQ211639                             I/W AFR-1                    DQ211626
  **ArD15786**             Senegal        1972       I/W AFR-1                    DQ211640                             \-                           \-
  **Semunya**              Uganda         1958       II/CENTRAL AFR               DQ076413                                                          
  **UG3010**               Congo          1956       II/CENTRAL AFR               DQ211650                             I/W AFR-1                    DQ211637
  **Hodzha**               Uzbekistan     1967       IV/ASI-2                     AY223475                             III/S AFR,W AFR-2            AY223476
  **HU8966**               Tajikistan     1990       \-                           \-                                   III/S AFR,WAFR-2             AY179962
  **AP92**                 Greece         1975       VI/GREECE                    DQ211638                             VI/GREECE                    DQ211625
  **Oman**                 Oman           1997       IV/ASI-1                     DQ211645                             IV/ASI                       DQ211632
  **Dubai 616**            Dubai          1979       IV/ASI-2                     JN108025                             \-                           \-
  **Kelkit06**             Turkey         2006       V/EUR                        GQ337053                             \-                           \-
  **200310849**            Turkey         2003       V/EUR                        DQ211649                             V/EUR                        DQ211636
  **KT281/75**             \-             \-         Dugbe virus                  AF434165                             \-                           \-
  **JC280**                Pakistan       1992       Hazara virus                 M86624                               \-                           \-

The sequence alignment was performed by ClustalW and a scaled phylogenetic tree generated by the Maximum Likelihood (ML) with Kimura 2-parameter distance using Mega5 software. Bootstrap confidence limits were based on 1000 replicates. This method evaluates the topologies of different trees and chooses the best tree based on a specified model. This model is based on the evolutionary process that can account for the conversion of one sequence into another ([@B32], [@B2]).

Results
=======

Viral RNA was extracted from 50 selected sera of infected patients originated from 19 provinces of Iran including Khorasane-Razavi, Khorasane-Jonobi, SistanvaBalochestan, Kerman, Tehran, Gilan, Mazandaran, Isfahan, Yazd, Qom, Azarbaijane-Sharghi, Azarbaijane-Gharbi, Zanjan, Kermanshah, Hormozgan, Fars, Boshehr, Khuzestan and Lorestan collected between 2002 and 2013.

Samples included in this study were correlated to the prevalence of the CCHFV from each region. Accordingly, 11 sera were selected from the Southeast of Iran, 10 sera from Central Iran, 9 sera from Northeast Iran, 8 sera from Southern Iran, 4 sera from West, 3 sera from Northwest, 3 serum samples from North, 1 serum sample from East and 1 serum sample from Southwest.

Partial sequence phylogenetic analysis of S segment
---------------------------------------------------

The phylogenetic analysis conducted by the Neighbor Joining (NJ) and Maximum-Likelihood (ML). Only ML are presented here, however phylogenetic tree that were created using the NJ algorithm had the same topology and strongly supported the same phylogenetic groups as the ML tree.

Phylogenetic analysis using the partial S-segment (∼500 bp) demonstrated, of 50 sequenced CCHFV obtained from Iranian patients, 40 sequences (80%), mainly in the Southeast and East of Iran, were located within clade IV (Asia 1). Two Iranian sequences (4%), both in the Southeast of Iran, formed a distinct cluster in the clade IV (Asia 2). These two Iranian sequences fell in the subgroup consisting of the India. Notably, two sequences had strong similarity to each other with 100 % bootstrap support. Seven sequences (14%) of Iranian strains, mainly in the Northwest of Iran, were located within clade V (Europe). One sequence (Iran-Kerman/22) showed itself as out-group and had the highest differences with other clades.

No Iranian sequences were positioned within clade III (S Africa and/or W Africa 2), clade II (Central Africa), clade I (W Africa 1), and clade VI (Greece AP92).

As expected, all sequences from an outbreak in Mashhad city, Khorasane-Razavi province, in 2012 grouped in a cluster with the highest similarity to each other (Iran-KhRazavi 2, 3, 4, 5, 16 and 17) ([Fig. 1](#F1){ref-type="fig"}).

![Phylogenetic tree of CCHFVs based on the 520-nucleotide S RNA sequences. The tree was constructed by using the maximum likelihood method with Mega 5. The sequences obtained from this study are shown by asterisk. The numbers above the branches indicate the bootstrap values in percentages (of 1000 replicates)](JAD-10-127-g001){#F1}

Complete genome sequence phylogenetic analysis of S segment
-----------------------------------------------------------

The topology of complete genome sequence analysis of S-segment (∼1500 bp) was in accordance with partial genome sequence analysis of the S-segment. The phylogeny of the complete S segment nucleotide sequences from strains obtained in Gene-Bank indicated that eight major groups could be recognized. The Iranian S segment from strain Iran-Kerman/22 was least similar to all other S segments and stands as an out-group and considered as clade VII (Iran) ([Fig. 2](#F2){ref-type="fig"}).

![Phylogenetic tree of CCHFVs full-length S RNA sequences (1500 bp). The tree was constructed by using the maximum likelihood method with Mega 5. The sequences obtained from this study are shown by asterisk. The numbers above the branches indicate the bootstrap values in percentages (of 1000 replicates)](JAD-10-127-g002){#F2}

Partial sequence phylogenetic analysis of M segment
---------------------------------------------------

Based on phylogenetic analysis on the partial sequence of M segment (∼520 bp), six clades were distinguishable. The tree showed that seven Iranian strains clustered in the clade III (S Africa and/or W Africa) and V (Europe) with other strains of Middle East and Europe.

The Iranian CCHFV strains Iran-Kerman/43, Iran-Tehran/65 and Iran-KhRazavi/72 in accordance with the Iranian strains (DQ 446216 and DQ446215) formed a separate cluster within the clades III and showed maximum closeness with the Pakistan (AJ 538199). In addition, Iran-Gilan/69 and Iran-Isfahan/78 strains fell in clade V (Europe) and showed maximum association with the isolates from Russia, Kosovo and Turkey. Interestingly, Iran-Kerman/22 showed the highest similarity to clade V in the M segment analysis ([Fig. 3](#F3){ref-type="fig"}).

![Phylogenetic tree of CCHFVs partial M RNA sequences (500 nucleotides). The tree was constructed by using the maximum likelihood method with Mega 5. The sequences obtained from this study are shown by asterisk symbol. The numbers above the branches indicate the bootstrap values in percentages (of 1000 replicates)](JAD-10-127-g003){#F3}

Discussion
==========

In 1992, the first complete nucleotide sequence of S-RNA segment of Chinese strain C68031 of CCHFV was determined ([@B21]). Afterwards, during an outbreak of CCHF in the United Arab Emirates between 1994 and 1995, nested reverse transcriptase polymerase chain reaction (RTPCR) amplifying of the partial S-RNA segment of CCHF virus was developed and used for analysis of CCHFVs ([@B29]).

Phylogenetic studies relied on the sequence data of the S-RNA segment have demonstrated genetic diversity for many CCHFV strains from different regions of the world ([@B19]). Despite the fact that recombination is relatively scarce in CCHFV genome ([@B6]) and a partial sequence of S-RNA segment can be used for phylogenetic analyses, but it is recommended to use the full sequence data of the SRNA segment for obtaining more precise phylogenetic analysis, as the possibility of recombination is still expected ([@B20]).

There have been several genetic analyses of CCHFVs obtained from Iran; however, all the reported Iranian strains were obtained mostly from the South-East of Iran and just four obtained from Central and recently one strain from the Northern regions of Iran ([@B8], [@B11], [@B10], [@B7]). What makes this study unique is in that a large number of CCHFV strains have been characterized genetically by partial and complete nucleotide sequencing of virus small (S) and medium (M) segments with a wide geographical distribution. Fifty partial sequences of S segment and six partial sequences of M segment and seven complete sequences of S segments from various locations have been studied.

In this study, we have used a bioinformatics approach to analyze an alignment by estimating the phylogenetic relationship between the obtained sequences from Iranian patients and GenBank available data. Phylo-genetic analysis based on large collections of partial and complete sequences of the S segment has indicated the existence of eight distinct clades for CCHFV ([@B13]). Accordingly, the most surprising finding in this study is discovery of a novel genomic variant of CCHFV. In other words, this study suggests the emergence of VII-IRAN clade for CCHFV in Iran as a novel clade based on S segment analysis.

In general, this phylogenetic analysis based on sequences of S-RNA of CCHFVs reveals that the majority of CCHFV sequences from Iran belongs to clade IV (Asia 1), and clade V (Europe), which is in consistent with previous reports from Iran ([@B11], [@B9]). In addition, for the first time, two sequences (Iran-Zahedan/19 and Iran-SistanBalochestan/85, which were obtained from the South-East Iran, were seen within clade IV (Asia 2) with the highest proximity to strains from India (JN572089).

The data of this study are in conformity with previous studies which showed similarity between Iranian S segment of CCHFV strains with Pakistan, Afghanistan ([@B11]) and Iraq ([@B8]), Interestingly findings regarding all phylogeny studies during these years is that CCHFV strain Iran/ArTec 193-3 is likely fade away from Iran and it has been never reported since 35 years ago when it was reported as the first CCHFV strain from Iran by Sureau ([@B31]).

Our data based on the S segment shows that CCHFVs are grouped in eight different clades and have correlation with their geographical location ([@B24]). Previous phylogenetic studies based on LRNA segment sequences have showed that the L tree topology is similar to the S tree topology ([@B18]). However, the phylogenetic topology based on M-RNA segment sequences of CCHFVs is different from that of S-RNA segments ([@B30], [@B1]). These analyses show that CCHFVs are likely to be grouped in six different phylogenetic clades based on M-RNA sequences ([@B12], [@B3]).

To obtain a phylogenetic tree based on M segment, a partial sequence data can be used ([@B24]), indicating that recombination within the M segments is not common during evolution of the CCHFVs. However, genetic re-assortment occurs frequently in CCHFVs, when host ticks co-infected with different types of CCHFVs ([@B12]). The reason why M-RNA segment re-assortment is more frequently observed is not clear, however, strong interrelation between N protein encoded in the SRNA segment and RNA polymerase encoded in the L-RNA segment may be required to produce viable virus ([@B4]).

Different examples of RNA segment re-assortment can be seen in the M segment phylogenetic tree. Tree based on M segment nucleotide and deduced amino acid sequence differences were very similar to each other. Like Mauritanian strain ArD39554 that belongs to group III in S and stands as an out-group VII in M segment trees, surprisingly in our obtained strains, the Iranian strain Iran-Kerman/22 forms a unique group and considered as clade VII in S tree ([Fig. 2](#F2){ref-type="fig"}), whereas it grouped within group V (Europe) with 100 % bootstrap support for this topology in M tree ([Fig. 3](#F3){ref-type="fig"}), suggesting that it representing M segment re-assortment.

Other potential M segment re-assortment events include Iranian strains Iran-Kerman/43 and Iran-KhRazavi/72 that were in group IV (Asia 1) in S tree, while cluster within group III in the M segment tree.

Conclusion
==========

The CCHFVs in Iran have multiple origins with vivid geographical relationships between virus strains. Moreover, phylogenetic results reveal subtle links between distant geographical locations, which may originate either from livestock trade or from long-distance carriage of virus by infected ticks during bird migration.

According to all previous phylogeny studies, four genetic lineages of CCHF viruses, clade IV (Asian 1 and II), clade V (Europe) and new clade VII (Iran) exist in Iran. Based on mentioned above data, having a high genomic variation of CCHFV, have been made Iran as a miniature model of the world for genetic analysis of CCHFV with various strains for CCHFV.
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